
Journal of Organic Chemistry p. 4873 - 4892 (2019)
Update date:2022-08-04
Topics:
Barnes, David M.
Shekhar, Shashank
Dunn, Travis B.
Barkalow, Jufang H.
Chan, Vincent S.
Franczyk, Thaddeus S.
Haight, Anthony R.
Hengeveld, John E.
Kolaczkowski, Lawrence
Kotecki, Brian J.
Liang, Guangxin
Marek, James C.
McLaughlin, Maureen A.
Montavon, Donna K.
Napier, James J.
Dasabuvir (1) is an HCV polymerase inhibitor which has been developed as a part of a three-component direct-acting antiviral combination therapy. During the course of the development of the synthetic route, two novel coupling reactions were developed. First, the copper-catalyzed coupling of uracil with aryl iodides, employing picolinamide 16 as the ligand, was discovered. Later, the palladium-catalyzed sulfonamidation of aryl nonaflate 33 was developed, promoted by electron-rich palladium complexes, including the novel phosphine ligand, VincePhos (50). This made possible a convergent, highly efficient synthesis of dasabuvir that significantly reduced the mutagenic impurity burden of the process.
View Morewebsite:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
SPRING CHEMICAL INDUSTRY CO.,LTD
Contact:86-187-66672125
Address:linchi industry park.zouping
Contact:18669908765
Address:Zibo City, Shandong Province, P.R.China
Shanghai Dianyang Industry Co.,ltd
Contact:+86 21 6492 4669
Address:Chejing RD, Songjiang District, Shanghai, China
TIANJIN DONGRUXIANG MINERALS MARKETING CO.,LTD(expird)
Contact:22-58516360
Address:tianjin
Doi:10.1021/jo5021618
(2014)Doi:10.1021/ja00436a040
(1976)Doi:10.1248/cpb.24.1033
(1976)Doi:10.1007/BF00510097
()Doi:10.1007/BF00904476
(1976)Doi:10.1016/j.tetlet.2011.08.136
(2011)